AUSUPREME (02031) releases annual performance: net profit of HKD 37.351 million for the year, a year-on-year increase of 33.82%.
Australia Supreme (02031) announced its financial results for the year ended March 31, 2026, with a profit of HK $ 300 million, an increase of 11.38% year-on-year; net profit for the year was HK $ 37.351 million, an increase of 33.82% year-on-year; basic earnings per share were 4.9 Hong Kong cents.
AUSUPREME (02031) announced its performance for the fiscal year ending on March 31, 2026, with a revenue of HK$300 million, representing an 11.38% year-on-year growth. The net profit for the year was HK$37.351 million, showing a 33.82% increase, and the basic earnings per share were 4.9 HK cents.
The announcement stated that the group's revenue mainly came from specialty stores, consignment counters, and e-commerce sales channels. The primary types of products are health supplements, personal care products, and honey and pollen products.
Related Articles
On June 26, CSTONE PHARMA-B (02616) spent HK$1.8533 million to repurchase 421,000 shares.
SYNERTONE (01613) issued 1 billion shares for sale.
XH NEWS MEDIA (00309) released its annual performance, with shareholders' losses amounting to 13.312 million Hong Kong dollars, a 78.8% increase year-on-year.
On June 26, CSTONE PHARMA-B (02616) spent HK$1.8533 million to repurchase 421,000 shares.
SYNERTONE (01613) issued 1 billion shares for sale.
XH NEWS MEDIA (00309) released its annual performance, with shareholders' losses amounting to 13.312 million Hong Kong dollars, a 78.8% increase year-on-year.
RECOMMEND
